According to the study, Oxford designates that AstraZeneca is effective covid-19 vaccine against the brazil version.
The primary data obtained from study conducted at Oxford shows that the covid-19 vaccine by AstraZeneca is effective against P1, Brazilian variants.
Data Shows covid-19 vaccine will not need to be modified
As the data suggests, the covid-19 vaccine will not need to be modified to protect against variants.
It is believed that the source originated in the Amazonian city of Manaus which is not yet made public.
The sources did not provide the exact efficiency of the vaccine against the variant.
Even he said that the full results of the study should be released soon.
The results suggest that the AstraZeneca vaccine was less effective against South Africa, later preventing the use of the vaccine in the country.
Information from a small sample study suggests that the coronavirus 19 vaccine developed by China Sinovac may not work effectively against Brazilian variants.
The representative for Astra Zeneca and the University of Oxford did not immediately respond to a request for comment.
Brazil currently faces a ferocious and long-lasting second wave of the Coronavirus, breaking the 1910 death record in a single day.
The P1 variant is one of the factors that epidemiologists believe is contributing to an increase in cases of death.
Even, there was concern about the resistant version of the vaccine.
Well, in the early times, the Astra Zeneca vaccine was much less effective than the African version.
So they have stopped using the vaccine.
But no one is sure about anything. Thoroughly completed studies will be released as soon as possible.
Also Read:
- Moderna Updated Covid Vaccine Shines Against the ‘Eris’ Variant
- Covid vaccine shows 95% protection against coronavirus
- All about Covid-19 Vaccine Registration in India for above 18 years
- Why herd immunity is difficult to achieve in India?
1 Comment